2Rasmussen HS, Mclann PP. Matrix Metalloproteinase inhibition as a novel anticancer strategy:a review with special focus on batimastat and matimastat. Pharmacol Ther, 1997, 75:69 - 75.
3Borkakoti N. Matrix Metalloproteinases:variations on a theme. Prog Biophys Mol Biol, 1998, 70:73 - 94.
4Saarialho-Kere U, Kerkela E, Jahkola T, et al. Epilysin(MMP-28)expression is associated with cell proliferation during epithelial repair. J Invest Dermatol, 2002,119:14 -21.
6Nerlov C, Rorth P, Blasi F, et al. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-speclfic activity. Oncogene, 1991, 6:1583 - 1592.
7Cecile D, Bernhard B, Georg FH, et al. Regulation of Metalloproteinases-2 and -9 by interleukin 13 in mesangial cells. Nephrol Dial Transplant, 2003, 18 (Suppl):254.
8Koide H, Nakamura T, Eblhara I, et al. Increased mRNA expression Metalloproteinase-9 in peripheral blood monocytes from patients with immunoglobulin A nephropathy. Am J Kidney Dis. 1996, 28:32 - 39.
9Urushihara M, Kagami S, Kuhara T, et al. Glomerular distribution and gelatinolytic activity of Matrix Metalloproteinases in human glomerulonephritis. Nephrol Dial Transplant, 2002, 17 : 1189 - 1196.
10Steinmann-Niggli K, Ziswiler R, Kung M, et al.lnhibition of Matrix Metalloproteinases attenuates anti-Thyl.1 nephritis. J Am Soc Nephrol., 1998, 9:397 - 407.
二级参考文献17
1王文欣，中国中西医结合杂志，2000年，20卷，12期，923页
2Rankin C A，J Am Soc Nephrol，1999年，10卷，2期，210页
3Steinmann Niggli K，J Am Soc Nephrol，1998年，9卷，3期，397页
4Schnaper HW. Balance between matrix synthesis and degradation: a determinant of glomerulosclerosis. Pediatr Nephrol, 1995, 9: 104-111.
5Sakai H, Jinde K, Suzuki D, et al. Localization of glycated proteins in the glomeruli of patients with diabetic nephropathy. Nephrol Dial Transplant, 1996, 11 Suppl 5 : 66-71.
6Miyazaki M, Koji T, Furusu A, et al. In situ hybridization studies of stromelysin and tissue inhibitor of metalloproteinase 1 in IgA nephropathy. Nephrology, 1995, 1: 119-127.
7Lee SM, Rao VM, Franklin WA, et al. IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol, 1982, 13: 314-322.
8Okada H, Suzuki H, Konishi K, et al. Histological alterations in renal specimens as indicators of prognosis of IgA nephropathy. Clin Nephrol, 1992, 37: 235-238.
